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Background: The rapid adoption of image-guidance in prostate intensity-modulated radiotherapy (IMRT) results in
longer treatment times, which may result in larger intrafraction motion, thereby negating the advantage of
image-guidance. This study aims to qualify and quantify the contribution of image-guidance to the temporal
dependence of intrafraction motion during prostate IMRT.
Methods: One-hundred and forty-three patients who underwent conventional IMRT (n=67) or intensity-modulated
arc therapy (IMAT/RapidArc, n=76) for localized prostate cancer were evaluated. Intrafraction motion assessment
was based on continuous RL (lateral), SI (longitudinal), and AP (vertical) positional detection of electromagnetic
transponders at 10 Hz. Daily motion amplitudes were reported as session mean, median, and root-mean-square
(RMS) displacements. Temporal effect was evaluated by categorizing treatment sessions into 4 different classes:
IMRTc (transponder only localization), IMRTcc (transponder + CBCT localization), IMATc (transponder only
localization), or IMATcc (transponder + CBCT localization).
Results: Mean/median session times were 4.15/3.99 min (IMATc), 12.74/12.19 min (IMATcc), 5.99/5.77 min (IMRTc), and
12.98/12.39 min (IMRTcc), with significant pair-wise difference (p<0.0001) between all category combinations except for
IMRTcc vs. IMATcc (p>0.05). Median intrafraction motion difference between CBCT and non-CBCT categories strongly
correlated with time for RMS (t-value=17.29; p<0.0001), SI (t-value=−4.25; p<0.0001), and AP (t-value=2.76; p<0.0066),
with a weak correlation for RL (t-value=1.67; p=0.0971). Treatment time reduction with non-CBCT treatment categories
showed reductions in the observed intrafraction motion: systematic error (Σ)<0.6 mm and random error (σ)<1.2 mm
compared with ≤0.8 mm and <1.6 mm, respectively, for CBCT-involved treatment categories.
Conclusions: For treatment durations >4-6 minutes, and without any intrafraction motion mitigation protocol in place,
patient repositioning is recommended, with at least the acquisition of the lateral component of an orthogonal image
pair in the absence of volumetric imaging.
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Intensity-modulated radiotherapy (IMRT) techniques
for prostate cancer facilitate safe dose escalation through
maximization of the therapeutic ratio with proven ben-
efits on local recurrence and biochemical control rates
[1,2]. Given the very conformal nature of IMRT treat-
ment plans, accurate patient positioning utilizing
image-guidance systems is of the utmost importance
[3]. Commercial availability of real-time or near-real-
time monitoring devices [4-7] has permitted detailed
evaluation of intrafraction prostate motion. Conse-
quentially, it is now known that for a typical radiotherapy
fraction, motion is largest in the antero-posterior
and cranio-caudal axes [8,9], and that the probabil-
ity of intrafraction motion has a temporal depend-
ence [5,10,11]. The latter finding is vital, as IMRT
treatment times are typically longer than their con-
ventional counterparts.
Curtis et al. [7] recently showed that with volumetric
image-guidance every 4 minutes, a 3-mm margin is suf-
ficient to account for intrafraction motion errors in the
absence of positional correction measures based on real-
time continuous tracking of the prostate. Shelton et al.
[6], however, showed that an optimized workflow with
faster treatment techniques, such as intensity-modulated
arc therapy (IMAT), allows for a significant decrease
in prostate intrafraction motion errors. Therefore, the
current study aims to evaluate the temporal dependence
of intrafraction motion of the prostate gland on image-
guided IMRT techniques in the absence of positional
correction measures based on real-time continuous track-
ing of the prostate. We hypothesize that the addition of
image-guidance on prostate IMRT results in signifi-
cantly longer treatment times, resulting in significant
intrafraction motion error.
Methods
Patient population and treatment planning
The current retrospective analysis was approved by our
Institutional Review Board (IRB), with patient informed
consent waiver. Medical records of patients that under-
went prostate IMRT or IMAT between September 2007
and July 2011 were reviewed. A cohort of 143 patients
(mean/median age: 68/67; range: 51–87) with histologi-
cally confirmed clinical stage I-III prostate adenocarcin-
oma formed the basis of the current analysis.
Simulation and radiotherapy planning techniques have
been reported previously [12]. In brief, simulation com-
puted tomography (CT) images were acquired in the
treatment position with the patient supine and trans-
ferred to a three-dimensional dosimetric planning plat-
form (Pinnacle3 v7.6, Philips Medical Systems, Andover,
MA or Eclipse v8.6/8.9, Varian Medical Systems, Inc.,
Palo Alto, CA, USA) for structure segmentation andtreatment planning. Seven to 9-field step-and-shoot or
sliding window IMRT plans (n=67) were computed for a
prescribed dose of 70 Gy (2.5 Gy/28 fractions) or 78 Gy
(2 Gy/39 fractions). Two sequential-arc (358° each)
IMAT plans (n=76) were computed for a prescribed
dose of 70 Gy (2.5 Gy/28 fractions).
Daily target localization and intrafraction motion analysis
Patient setup procedures have also been previously de-
scribed [12]. In brief, daily localization was based on
electromagnetic transponder detection, validated at least
weekly by volumetric cone-beam CT (CBCT; Varian Med-
ical Systems, Palo Alto, CA, USA). Intrafraction motion of
the prostate gland was monitored in real-time with 1/
10th s update of the lateral (LR/X), vertical (AP/Y), and
longitudinal (SI/Z) displacement of the localized target
isocentre. Sustained deviations >4 mm in any transla-
tional direction prompted corrective action while transient
deviations lasting <1 second were ignored. Tracking data
points, obtained immediately post electromagnetic trans-
ponder localization and up to 30 s after dose administra-
tion, were used for the current evaluation. Tracking data
with unusually large displacement of the target isocentre
at the terminal portion of the tracking session (due to mo-
tion of the patient support assembly or treatment couch
prior to discontinuation of real-time tracking) were ex-
cluded. Records of treatment fractions that were corrupted
(i.e., containing no tracking data) were also excluded.
Intrafraction positional error estimation
Tracking sessions were separated into 4 distinct “treat-
ment categories:” IMRTc (n=1226; IMRT sessions with
setup based on electromagnetic transponders only),
IMRTcc (n=864; IMRT sessions with setup based on
electromagnetic transponders plus CBCT verification),
IMATc (n=1461; IMAT sessions with setup based on
electromagnetic transponders only) and IMATcc (n=586;
IMAT sessions with setup based on electromagnetic
transponders plus CBCT verification). Digital tracking
data and associated time stamps were downloaded to
Microsoft Excel (2007; Microsoft, Redmond, WA, USA)
for processing. The root-mean-square (RMS) distance
was calculated for each time point.
For reporting the individual directional components of
target motion, the absolute values of motion displace-
ments were used. For the purpose of this study, +X, +Y,
and +Z coordinates defined displacement to the left,
posterior, and superior directions from isocentre, re-
spectively. Daily directional components were synchro-
nized at each time point, and the population-based
average computed for each treatment category was
used to evaluate motion trend over time. Daily treat-
ment couch corrections for sustained deviations >4
mm were reported.
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each daily session into an analyzable endpoint for the
entire cohort, the median observed absolute displace-
ment was used. Furthermore, for each treatment cat-
egory, population-based mean (M), systematic (Σ), and
random (σ) errors were computed for each motion dir-
ection. Population-based effect of treatment duration
on intrafraction motion amplitude was also assessed by
computing displacement probabilities as a function of
displacement and time.
Statistical analysis
Correlations between outcome (dependent) variable and
effect variables were analyzed using a linear mixed effects
model. The primary outcome of interest was intrafraction
motion (median LR, median SI, median AP, and median
RMS) and the measured covariate was session treatment
time. Subject specificity served as random effect while the
fixed (main) effect was the treatment category (IMRTc,
IMRTcc, IMATc, and IMATcc). Heterogeneity between
treatment categories was taken into account. Hypothesis
testing for all pair-wise comparisons were adjusted for the
family-wise errors across multiple comparisons at the 0.05
level using the Bonferroni correction. All statistical ana-
lyses were performed using SAS statistical software (ver-
sion 9.0; SAS Inc, Cary, NC, USA).
Results
Magnitude and duration of prostate displacement
Figure 1 summarizes the duration of treatment sessions
per treatment category. The observed mean/median ses-
sion duration were 4.15/3.99 min (IMATc), 5.99/5.77 minFigure 1 Box-and-whisker plots of the distribution of treatment
session times for each treatment category. Whiskers denote the
nearest values <1.5 times the interquartile range (IQR), open circles
beyond the whisker lines (o) indicate individual outliers (<3.0 times
the IQR), and stars (*) signify extreme values (>3.0 times the IQR).(IMRTc), 12.74/12.19 min (IMATcc), and 12.98/12.38 min
(IMRTcc); overall range: 1.8 min (IMRTc) to 51.8 min
(IMRTcc). Pair-wise comparison between treatment cat-
egories showed significant differences (p<0.0001), except
for IMRTcc vs. IMATcc (p>0.05). Although not the original
intent of the current study, a comparison between CBCT
(least square mean = 12.88 min) and non-CBCT (least
square mean = 4.99 min) categories also showed a statisti-
cally significant difference (least square mean difference =
7.90 min; p<0.0001).
The probability of isocentre displacement from refe-
rence position is presented in Figure 2. For the purpose
of histogram analysis, displacement from the reference
position was divided into 0.25-mm increments. Move-
ment was most prominent in the SI and AP dimensions
in all four tracking categories. Table 1 summarizes the
fraction of time the treatment isocentre deviated from
its reference position by ≥0 mm, ≥1 mm, ≥2 mm, ≥3
mm, or ≥4 mm in the LR, AP, and SI directions. Lon-
gitudinal (SI) motion for treatment categories that
included volumetric imaging showed the greatest vari-
ability: 17.6% vs. 11.1% of IMRT sessions and 22.2% vs.
9.8% of IMAT sessions had displacement values ≥2 mm.
On the other hand, LR motion showed very little vari-
ation, again with the most variability observed with the
use of volumetric image-guidance. Deviations >5 mm
were rare in any dimension secondary to the use of a 4-
mm action level corrective intervention protocol. Over-
all, Table 2 indicates a posterior and inferior prostate
drift, with the inferior drift more pronounced than the
posterior.
Intra-treatment table adjustments
Treatment couch adjustments occurred 601 times out of
4137 treatment sessions. The incidence of required
intra-treatment patient support assembly adjustment
was as low as 6.6% (IMATc) to 8.3% (IMRTc) and as high
as 27.2% (IMRTcc) to 28.3% (IMATcc). The incidence of
treatment couch adjustment was 0.5% in the LR, 30.3%
in the AP, and 69.2% in the SI directions, respectively.
As expected, the accumulated incidence of table position
adjustment was significantly higher for the techniques
with longer session duration (IMRTcc and IMATcc) com-
pared with their shorter equivalent (IMRTc and IMATc)
in all motion directions. Furthermore, treatment couch
adjustments, on average, occurred as early as 2.4 mi-
nutes into a tracking session, with the vast majority of
table adjustments for the longer treatment sessions oc-
curring onwards of 4.5 minutes (Table 2).
Prostate displacement as a function of time
Median motion difference amongst treatment categories
in the LR direction showed significant difference be-
tween IMRTc vs. IMATc (p=0.0003) and between IMATc
Figure 2 Histogram analysis showing the probability of displacement of beacon centroid as a function of motion amplitude.
Displacement is measured along the lateral (LR), longitudinal (SI), and frontal (AP) directions for IMRTc (A), IMRTcc (B), IMATc (C), and IMATcc (D).
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difference was observed between IMRTc vs. IMRTcc
(p=0.0176) and between IMRTc vs. IMATcc (p=0.0349).
In the SI direction, significant difference was observed
between IMRTc vs. IMATcc (p=0.0003) and between
IMATc vs. IMATcc (p=0.0021). When adjusted for treat-
ment time, significant difference was observable only be-
tween IMRTc and IMATc (p=0.0024) in the LR direction.
Notwithstanding, median motion difference between
CBCT and non-CBCT tracking sessions showed strong
correlation with time for RMS (t-value=17.29; p<0.0001),
SI (t-value=−4.25; p<0.0001) and AP (t-value=2.76;
p<0.0066), and weak correlation for LR motion
(t-value=1.67; p=0.0971).
The mean displacement in the LR and AP directions
trended toward 0 mm for the majority of the sampled
time points (Figure 3); relating to the fact that deviations
were approximately equally distributed in the positive
and negative directions. In the LR direction, the stand-
ard deviation never exceeded 1 mm; however, the stand-
ard deviation was up to 1.5 mm in the AP direction. In
the SI direction, the prostate was perceived to drift infer-
iorly (Figures 2 and 3) and the mean displacement was
≥0.5 mm for techniques with longer treatment session
duration (IMATcc and IMRTcc), with a standard deviationexceeding 1.5 mm (for IMATcc and IMRTcc), see Table 2.
To further evaluate the effect of time on intrafraction mo-
tion, tracking session motion of 1 mm amplitude incre-
ments were evaluated over 1-minute intervals (up to the
mean tracking time for each corresponding treatment cat-
egory). When plotted sequentially (Figure 4), an unam-
biguous trend of increasing motion with time was evident.
Table 2 summarizes the results of the observed motion
differences between the different treatment categories, in-
dicating that geometric errors increase with increasing
tracking time, with the greatest discrepancy observed in
the SI followed by the AP direction.
Discussion
Multiple studies [13,14] have shown that for treatment
session time frames shorter than that for image-guided
IMRT techniques, intrafraction displacement of the
prostate position is insignificant. However, cine magnetic
resonance imaging studies [15,16] have shown significant
prostate motion at time periods larger than 7 to 9.5 mi-
nutes, and have validated the correlation between pros-
tate motion and rectal distension [12,17]. In recent
years, high sampling rate (that is, 10–30 Hz) fluoroscopic
and electromagnetic systems have been introduced to fa-
cilitate on-line setup correction and continuous positional
Table 1 Isocentre displacement for each treatment category
Treatment
category
Displacement [mm] Lateral [%] Vertical [%] Longitudinal [%]
Left Right Anterior Posterior Superior Inferior
IMRTc ≥0 53.7 46.3 51.2 48.8 35.6 64.4
≥1 7.1 4.7 16.9 16.2 9.9 24.9
≥2 0.8 0.6 4.5 4.6 3.9 7.2
≥3 0.1 0.1 1.1 1.3 1.6 1.7
≥4 0.0 0.0 0.2 0.4 0.7 0.3
IMRTcc ≥0 50.9 49.1 45.8 54.2 36.9 63.1
≥1 8.7 8.3 18.9 24.0 13.3 29.9
≥2 1.1 1.6 5.5 8.7 5.5 12.1
≥3 0.2 0.4 1.4 3.0 2.4 4.5
≥4 0.0 0.0 0.4 0.9 1.2 1.2
IMATc ≥0 48.2 51.8 47.4 52.6 32.4 67.6
≥1 3.8 5.6 13.1 14.5 9.0 24.4
≥2 0.2 0.5 2.4 3.8 3.8 6.0
≥3 0.0 0.0 0.3 1.1 1.8 1.6
≥4 0.0 0.0 0.1 0.4 0.9 0.2
IMATcc ≥0 54.6 45.4 47.6 52.4 31.3 68.7
≥1 9.5 5.4 17.5 20.8 11.0 38.3
≥2 1.5 0.8 4.5 6.9 4.4 17.8
≥3 0.2 0.1 1.0 1.8 2.0 6.8
≥4 0.0 0.0 0.1 0.3 0.9 1.7
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Consistent with the results of Shelton et al. [6], the
current study presents an assessment of the temporal de-
pendence of intrafraction motion on the prolongation of
treatment time with real-time tumor tracking of electro-
magnetic transponders. Furthermore, the current study
evaluated the impact of the addition of volumetric image-
guidance onto IMRT techniques with the use of real-time
localization and tracking. The major findings in the
current study demonstrate that treatment time reduc-
tion for radiotherapy techniques without volumetric
image-guidance resulted in significant reductions in
motion error; Σ <0.6 mm and σ <1.2 mm compared
with Σ ≤0.8 mm and σ <1.6 mm. The current findings
are consistent with recent results by Mutanga et al.
[18] for mean treatments time <5 minutes vs. >11 mi-
nutes. The current findings are also generally consist-
ent with prior reports by Kotte et al. [10] for short (5–7
minutes) treatment durations.
For each treatment technique evaluated in this study,
target displacements progressively increased as a function
of elapsed treatment session duration (Figure 2). These
findings may be attributable to increased motion around
the mean position of the prostate, either internally (due to
bladder and/or rectal filling), or externally (due to patient
shifts) or related to gradual pelvic floor musculaturerelaxation [6]. Langen et al. showed that mean 3D mo-
tion >3 mm progressively increased with treatment time
from 2% (during the first minute) to greater than 25%
(after 10 minutes) [5]. The latter findings are in con-
cordance with trends observed by Curtis et al. [7] and
Xie et al. [19] for patients with treatment times >5 mi-
nutes and with the use of high and low sampling rate
motion assessment techniques. These findings are also
consistent with results in the current study (see poster-
ior and/or inferior prostate drifts in Table 1). Together,
these results are crucial, because intrafraction motion
significantly contributes to the systematic and random
errors of radiotherapy dose delivery [20] and may result
in overdosing to the bladder and/or rectum as well as
underdosing to the target volume.
Using a contribution of 2.5 times the systematic error
and 0.7 times the random error [20], one can demon-
strate that, for the shorter treatment categories (IMRTc
and IMATc), the required margins are 1.0–1.1 mm (LR),
2.0–2.1 mm (AP), and 2.0 mm (SI). While these margins
are consistent with those reported by Curtis et al. [7],
Kotte et al. [10], and Xie et al. [19], they are not in
agreement with those reported by Langsenlehner et al.
[21], in part due to undersampling of motion trajectory
with use of very low sampling rate techniques for target
motion interrogation in the latter study. Correspondingly,




Time to patient support assembly adjustment [min] Overall displacement






[σ, mm]25th Percentile Mean Median
LR AP SI LR AP SI LR AP SI LR AP SI LR AP SI LR AP SI LR AP SI
IMRTc – 2.4 2.1 – 3.7 3.4 – 3.4 3.1 0.1 ± 0.6 0.1 ± 1.2 −0.3 ± 1.3 0.05 −0.02 −0.31 0.27 0.5 0.49 0.6 1.09 1.18
IMRTcc 6.8 4.5 4.7 6.8 7.8 8.0 6.8 6.5 7.0 0.0 ± 0.8 0.1 ± 1.5 −0.5 ± 1.7 −0.07 0.08 −0.63 0.42 0.65 0.70 0.80 1.32 1.54
IMATc – 1.9 1.4 – 3.0 2.4 – 2.8 2.3 −0.1 ± 0.5 0.1 ± 1.1 −0.2 ± 1.4 −0.04 0.06 −0.33 0.25 0.57 0.53 0.54 0.90 1.16




















Figure 3 Histogram analysis showing the probability of displacement of treatment isocentre as a function of time for 1-mm
displacement intervals.
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categories (IMRTcc and IMATcc) are 1.5–1.6 mm (LR),
2.5 mm (AP), and 2.8–2.9 mm (SI). These are less than
the ideal margins proposed by Curtis et al. [7] with
volumetric imaging every 4 minutes to account for
intrafraction motion errors in the absence of positional
correction measures based on real-time continuous
tracking. It is important to note that the margins
reported here are not meant to define an absolute treat-
ment margin due to the fact that only observed target
motion is accounted for. Nevertheless, it is evident that
comparatively larger margins are required to provide
95% isodose coverage for 90% of the sessions for the
longer treatment categories. These large margins can be
substantially reduced by continuous monitoring, imple-
mentation of an action threshold to reduce the effects
of large motions, and keeping treatment sessions short—
in this case, shorter that 6 minutes.Clinical implications
Although the current results exhibit small intrafraction
motion over entire treatment sessions, they also show
that even with very accurate online position correction
at the start of a treatment session, some positioning un-
certainty remains and should be accounted for in mar-
gins. Aznar et al. [22] reported that when IMAT was
used to treat prostate cancer patients, it required less
than 2 minutes of beam-on time per treatment. In the
current study, within 2 minutes after initial patient setup
for daily treatment, the movement of the prostate was
limited, though not trivial. Results in the current study
suggest treatment session duration should not exceed 4–
6 minutes. For treatment duration ≥4-6 minutes, and
with the absence of real-time corrective measures for
intrafraction motion, it is prudent to incorporate repeat
patient localization [7]. Furthermore, in the absence of
volumetric image-guidance for repeat patient localization,
Figure 4 Population-based average treatment isocentre displacement as a function of elapsed time along the lateral (LR), longitudinal
(SI), and frontal (AP) directions and as a composite vector for IMRTc (A), IMRTcc (B), IMATc (C), and IMATcc (D).
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onal image pair needs to be performed, since AP and SI
directions are more susceptible to the temporal depen-
dence of intrafraction motion.
Additional clinical strategies to stabilize the prostate
gland with the goal of minimizing intrafraction motion
include a controlled diet [23] and rectum filling [24-27].
However, these strategies have not garnered widespread
clinical application, as their effectiveness when com-
pared with faster treatment techniques, such as IMAT, is
yet to be determined.
Limitations
Table adjustments were made for sustained prostatic dis-
placements that exceeded a predetermined 4 mm thres-
hold. Treatment interventions that occurred during
tracking sessions were not retrospectively corrected to
void the interventions. As such, the current analysis has
the potential to underestimate displacements, particularly
those >4 mm. The interpretation of the probability of dis-
placement results, while easily understood from a geomet-
ric perspective, may be difficult to implement from a
margin formation standpoint, hence, the application of
this information to the generation of margins in radiation
therapy may require additional evaluation.Conclusion
Significant reductions in margins can be achieved
through continuous tracking and intrafraction patient
repositioning by means of threshold-based interven-
tion. Prolonging treatment duration increases the like-
lihood of internal organ motion as well as external
movement due to patient discomfort, which can im-
pact overall treatment accuracy. Adopting treatment
protocols such as IMAT combined with electromagnetic
transponder detection and positioning, in addition to con-
tinuous monitoring of patient motion, provides an effi-
cient, effective, and accurate delivery of external beam
treatments. For treatment durations greater than 4–6 mi-
nutes and with no intrafraction motion mitigation proto-
col in place, patient repositioning is recommended, with
the acquisition of at least the lateral component of an or-
thogonal image pair in the absence of volumetric imaging.
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